Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies.

Hollander M, Mayer T, Klotz KA, Knake S, von Podewils F, Kurlemann G, Immisch I, Rosenow F, Schubert-Bast S, Strzelczyk A.

Open source

DOI: 10.1186/s42466-025-00408-w
Published: 2025-07-22
Container: Neurol Res Pract
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s42466-025-00408-w,
  title = {Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies.},
  author = {Hollander M and  Mayer T and  Klotz KA and  Knake S and  von Podewils F and  Kurlemann G and  Immisch I and  Rosenow F and  Schubert-Bast S and  Strzelczyk A.},
  year = {2025},
  journal = {Neurol Res Pract},
  doi = {10.1186/s42466-025-00408-w},
  url = {https://doi.org/10.1186/s42466-025-00408-w}
}

RIS

TY  - JOUR
TI  - Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies.
AU  - Hollander M
AU  -  Mayer T
AU  -  Klotz KA
AU  -  Knake S
AU  -  von Podewils F
AU  -  Kurlemann G
AU  -  Immisch I
AU  -  Rosenow F
AU  -  Schubert-Bast S
AU  -  Strzelczyk A.
PY  - 2025
JO  - Neurol Res Pract
DO  - 10.1186/s42466-025-00408-w
UR  - https://doi.org/10.1186/s42466-025-00408-w
ER  -

APA

M, H., T, M., KA, K., S, K., F, V. P., G, K., I, I., F, R., S, S., & A., S. (2025). Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies.. Neurol Res Pract. https://doi.org/10.1186/s42466-025-00408-w

Source records

europe-pmc · retrieved 2026-09-26T05:50:02.413Z
doaj · retrieved 2026-09-26T05:50:02.384Z